HIGHLIGHTS
- who: Fangjie Wang and colleagues from the Vanderbilt University Medical Center, United States have published the research work: Natural killer cells in sepsis: Friends or foes?, in the Journal: (JOURNAL)
- what: Autologous NK cell infusion using the patientu2032s own blood as a source was the first focus in adoptive NK cell therapy, which is associated with low risk of graft-versus-host disease . The authors postulate that NK cell-based immunotherapies may be developed as an excellent therapeutic option for sepsis, for the following reasons: 1.
SUMMARY
During the hyperinflammatory phase . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.